Skip to main content
. 2018 Jan 30;92(4):e01610-17. doi: 10.1128/JVI.01610-17

TABLE 1.

Percentages of GFP- or LT-positive cells in dermal fibroblasts treated with MCPyV pseudovirus, MCPyV, or MCPyV chimeric viruses

Source of fibroblasts % of GFP+ fibroblasts (mean ± SEMa) following exposure to MCPyV-GFP % of LT+ fibroblasts (mean ± SEMa) following exposure to:
MCPyV MCPyV-MuPyV MCPyV-SV40 A MCPyV-SV40 B
Human 15.13 ± 7.49 40.17 ± 4.80 4.00 ± 1.61 21.80 ± 3.39 33.33 ± 5.64
Mouse 0.87 ± 0.23 0 <0.01 0.07 ± 0.02 0.13 ± 0.04
Rabbit 46.30 ± 8.32 0 0.12 ± 0.04 <0.01 0.57 ± 0.23
Rat 33.33 ± 5.76 5.80 ± 2.48 3.17 ± 1.13 3.83 ± 1.10 52.77 ± 6.68
Chimpanzee 47.17 ± 9.59 43.67 ± 4.60 NA NA NA
Rhesus macaque 31.50 ± 6.37 0.81 ± 0.17 0.67 ± 0.32 3.16 ± 1.01 16.43 ± 5.57
Patas monkey 15.63 ± 3.23 0.40 ± 0.15 NA NA NA
Common woolly monkey 10.40 ± 2.58 0 NA NA NA
Red-chested mustached tamarin 9.47 ± 2.12 0 NA NA NA
Tree shrew 3.83 ± 1.34 0 NA NA NA
a

Data are from the results of at least three independent experiments. NA, not applicable.